CERIMON PHARMACEUTICALS
Cerimon Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics for autoimmune diseases, inflammation, and pains in the United States and Europe. It develops Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, including pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. Cerimon Pharmaceuticals, Inc. was founded in 2004 and is headquartered in South San Francisco, California.
CERIMON PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2004-01-01
Address:
South San Francisco, California, United States
Country:
United States
Total Employee:
11+
Status:
Active
Total Funding:
72.73 M USD
Similar Organizations
Alnara Pharmaceuticals
Alnara Pharmaceuticals develops and commercializes orally-delivered protein therapeutics for the treatment of metabolic diseases.
BioDtech
BioDtech develops and commercializes reagents and systems for the detection, neutralization, and removal of endotoxin for researchers.
BioMimetix Pharmaceutical
BioMimetix Pharmaceutical develops therapeutic compounds for various diseases and treatment ramifications such as radiation toxicity.
Cahaba Pharmaceuticals
Cahaba Pharmaceuticals develops novel therapeutics and supportive care products for cancer patients.
Cashel Neural
Cashel Neural develops and commercializes novel therapies for multiple sclerosis.
Fairhaven Pharmaceuticals
Fairhaven Pharmaceuticals is a developer of oral therapeutics intended to treat severe inflammatory conditions.
Ground Fluor Pharmaceuticals
Ground Fluor Pharmaceuticals develops new imaging agents for use in diagnosis and management of disease, and to help other companies.
Tivorsan Pharmaceuticals
Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
Phase4 Ventures
Phase4 Ventures investment in Series A - Cerimon Pharmaceuticals
OrbiMed
OrbiMed investment in Series A - Cerimon Pharmaceuticals
MPM Capital
MPM Capital investment in Series A - Cerimon Pharmaceuticals
More informations about "Cerimon Pharmaceuticals"
What happened to Cerimon? - Fortune
Dec 20, 2011 Cerimon kept putting out press releases about clinical trial advances and kept hiring new employees. Then Sekhri quietly left at the end of 2008, to join investment firm TPG …See details»
Cerimon Pharmaceuticals - Funding, Financials, Valuation
Cerimon Pharmaceuticals develops and commercializes therapeutics for autoimmune diseases, inflammation, and pains. New. Resources. Advanced Search. Start Free Trial . ... How much …See details»
Cerimon Pharmaceuticals Inc - Company Profile and News
Cerimon Pharmaceuticals, Inc. provides biopharmaceutical services. The Company develops, produces, and commercializes therapeutics for the treatment of autoimmune diseases, …See details»
Cerimon Pharmaceuticals - LinkedIn
Cerimon Pharmaceuticals | 58 followers on LinkedIn. ... Reiss-Davis Graduate School Higher Education Los Angeles, CaliforniaSee details»
Organization | Cerimon Pharmaceuticals
Cerimon Pharmaceuticals Report issue. For profit Phase 2 Phase 3. Founded: South San Francisco CA United States ... Organization Overview. First Clinical Trial. 2007 NCT00430898. …See details»
Cerimon Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Explore Cerimon Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 11 clinical trials, 1 news, Drug:Basiliximab.See details»
Cerimon Pharmaceuticals Inc. - BioCentury Company Profiles - BCIQ
Jul 27, 2022 Cerimon Pharmaceuticals Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Cerimon Pharmaceuticals - Crunchbase
Cerimon Pharmaceuticals develops and commercializes therapeutics for autoimmune diseases, inflammation, and pains.See details»
Cerimon Pharmaceuticals, Inc. in South San Francisco, California
The Employer Identification Number (EIN) for Cerimon Pharmaceuticals, Inc. is 20-1903723. EIN numbers are also referred to as FEIN or FTIN. Find EIN, Contact Details for Cerimon …See details»
Cerimon Pharmaceuticals - VentureRadar
Therapies for pain, autoimmune and inflammatory disease. ... Find out more about Cerimon Pharmaceuticals, Healthtech and Life Sciences.See details»
Cerimon Pharmaceuticals, Inc.:Company Profile & Technical …
Cerimon Pharmaceuticals is a company that provides Transdermal patch, Health care, Pharmacy and Therapeutics and more. Cerimon Pharmaceuticals is headquartered in United States …See details»
Cerimon Pharmaceuticals - Products, Competitors, Financials, …
Cerimon Pharmaceuticals, Inc. Use the CB Insights Platform to explore Cerimon Pharmaceuticals's full profile. Cerimon Pharmaceuticals - Products, Competitors, Financials, …See details»
Cerimon Pharmaceuticals, Inc. Licenses Exclusive Worldwide
Feb 21, 2006 About Cerimon Pharmaceuticals. Cerimon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to bringing innovative therapeutics to patients with …See details»
Cerimon Pharmaceuticals, Inc. in South San Francisco, California
Organization Name: Cerimon Pharmaceuticals, Inc. IRS EIN (Taxpayer Id) 20-1903723: Former Names: Cerimon Pharmaceuticals Inc (till 2005-11-01) Type of business: Business Address …See details»
Cerimon Pharmaceuticals rounds up $70M in VC
Oct 25, 2005 South San Francisco-based Cerimon Pharmaceuticals has raised a whopping $70 million in its first round of venture capital. CEO Paul Sekhri said that much of the money will go …See details»
Cerimon Pharmaceuticals, Inc. to Conduct a Proof of Concept
Mar 10, 2008 Cerimon Pharmaceuticals, Inc., is a biopharmaceutical company dedicated to developing and commercializing therapeutic products for autoimmune diseases, inflammation, …See details»
Cerimon Pharmaceuticals - Tech Stack, Apps, Patents & Trademarks
Organization. Cerimon Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 4. About. …See details»
Five Trends Reshaping Pharmaceutical Manufacturing Partnerships
Apr 23, 2025 The pharmaceutical manufacturing landscape is undergoing a profound shift, with contract development and manufacturing organizations (CDMOs) evolving from simple …See details»
Cerimon Pharmaceuticals - Updates, News, Events, Signals
Apr 13, 2016 Cerimon Pharmaceuticals raised $70,000,000 / Series A from MPM Capital and 2 other investors Discover more funding rounds Browse By: Organizations, People, EventsSee details»
Cerimon Pharmaceuticals - Contacts, Employees, Board Members, …
Organization. Cerimon Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Number of …See details»